Retrospective Description of Pregnant Women Infected with Severe Acute Respiratory Syndrome Coronavirus 2, France

Vivanti, Alexandre J.; Mattern, Jérémie; Vauloup-Fellous, Christelle; Jani, Jacques; Rigonnot, Luc; El Hachem, Larissa; Le Gouez, Agnès; Desconclois, Céline; Ben M’Barek, Imane; Sibiude, Jeanne; Benachi, Alexandra; Picone, Olivier; Cordier, Anne-Gaël

Fix data are available on the management of pregnant women infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a retrospective study of 100 pregnant women with SARS-CoV-2 infection in 4 obstetric units in the Paris metropolitan area of France during March 12–April 13, 2020. Among patients, 52 (52%) were hospitalized, 10 (10%) in intensive care units (ICUs). Women with higher body mass indexes (BMIs; median 30.7 kg/m(2)) were more likely to be hospitalized in ICUs than other women (median BMI 26.2 kg/m(2)). Women hospitalized in ICUs had lower lymphocyte count at diagnosis (median 0.77 × 10(9) cells/L) than women not hospitalized in ICUs (median lymphocyte count 1.15 × 10(9) cells/L). All women requiring oxygen >5 L/min were intubated. Clinical and laboratory evaluation of SARS-CoV–2−positive pregnant women at the time of diagnosis can identify patients at risk for ICU hospitalization.